Pharma

Biogen in $1.25 bln deal with Forward Pharma to protect MS drug

Biogen Inc (BIIB.O) said on Tuesday it would pay Forward Pharma A/S (FWP.O) $1.25 billion in cash to gain access to the Danish company's intellectual property as it seeks to protect the patent life of its flagship multiple sclerosis drug, Tecfidera.<p>The license agreement is subject to the approval …

21st Century

CES 2017 – Medical Device Top Picks

Connected tech was the overriding theme at this year's Consumer Electronics Show in Las Vegas. But among all that consumer gadgetry, there were some …

Digital Health

What'd you miss at J.P. Morgan? Everything you need to know, all in one place

The sun has set on the J.P. Morgan Healthcare Conference, but we're still digesting the multicourse meal of news and commentary we've come to expect …

Investing

Trump's latest pharma-fighting plan? Use Twitter to force prices down, manufacturing to U.S.

Pharma is fast becoming President-elect Donald Trump’s favorite whipping boy. Last month, Trump vowed to bring down drug prices. Last week, he …

Health Care

Big Pharma's Newest Headache: Rival Drugmakers

One of big pharma’s most lucrative markets is starting to attract a crowd.<p>Drugs known as TNF inhibitors, used to treat maladies such as rheumatoid arthritis, have long been among the industry’s best sellers. Major brands include AbbVie’s Humira, Amgen’sand Pfizer’s Enbrel and Johnson & Johnson’s …

Investing

Novartis takes biosimilar delay complaint to Supreme Court

<b>A landmark lawsuit that could allow biosimilars to be launched in the US market more quickly is scheduled to be heard in the Supreme Court in …

Investing

FDA extends review time for Lillys’ RA drug

US regulators have extended the review period for Eli Lilly and Incyte's baricitinib, a once-daily oral medicine submitted in January last year for …

Investing

Big Pharma Is Synthesizing Cannabis To Make A Patent-able Pill And It’s Killing People

Big Pharma is hurriedly attempting to imitate these same effects — in their labs.<p>By: Matt Agorist / The Free Thought Project Throughout the bodies of …

Life Sciences

Richard Curran: Trump is playing Russian roulette with Big Pharma

One might wonder about the unfortunate timing of the very good news that US pharmaceutical company IQ Pharmatek plans to create 100 jobs in Tipperary.

News (Ireland)

Op-Ed: Why Big Pharma should be afraid. Very afraid

It's becoming obvious Big Pharma's iron wall of protection in Washington is starting to crumble, says Jake Novak.

Bernie Sanders

Job Vacancy at a Leading Pharmaceutical Company – Peoplesource Consulting, Saturday 14, January 2017 2017 | Latest Jobs in Nigeria 2017- Recent Job Vacancies in Nigeria

Job Vacancy at a Leading Pharmaceutical Company – Peoplesource Consulting, Saturday 14, January 2017<p>Peoplesource Consulting is a team of experienced …

Employment

They Didn’t Choose To Be Refugees. But We Have A Choice Of How We Respond To Their Plight.

“Indifference is a disease.”<p>A teacher, a psychologist, a school principal, a pharmacist. These are just some of the people featured in the Doctors of …

Refugees

BI aims to boost chronic disease portfolio for people and pets post-Sanofi asset swap

On New Year’s Day, Sanofi and Boehringer Ingelheim closed a $12.5 billion asset swap that had been in the works for a year, giving the closely held …

Innovation

New York takes drug pricing into its own hands with new clampdown

As much of the pharma industry waits to see what kind of approach the incoming presidential administration will take on drug pricing, New York …

Health Care

Your company isn’t saving the world: Why you should stay there anyway

I once knew a guy named Brian. Brian was a recent college graduate and he wanted to work for an environmental nonprofit, but he couldn’t find a job. All of the organizations that interested him could only offer volunteer roles, and Brian needed to pay his rent.<p>Brian received a job offer in …

Business

Goldman likes GW Pharma, sees 56% upside

Goldman Sachs initiates coverage on GW Pharmaceuticals (GWPH +2.4%) with a Buy rating and $189 (56% upside) price target. Four other shops recently …

Wall Street

Biotechs: What The 'Trump Dump' And CVS's EpiPen Move May Mean

Biotechs sold off sharply this week when Donald Trump criticized pharma pricing and suggested Federal action against high drug prices.<p>Perhaps just as …

Finance

The Pharma 13—Never Forget Who They Are

While the Republican Party dismantles Americans’ healthcare, 13 Democrats sided with Big Pharma late Wednesday night. They voted against a budget …

Health

Novartis scouts new tech partnerships to build lead on 'risk averse' pharma peers

SAN FRANCISCO—Last January, Novartis CEO Joe Jimenez warned that tech was an area where pharma would have to “pay real attention.” One year later, …

Innovation

Bernie Blasts Dem Senators without "Guts" Who Voted for Big Pharma. Update with good Kos tweet.

Those who wonder why we lost to the vile Trump, Exhibit A is the vote this week in which 13 Senate Democrats voted for BIg Pharma instead of …

Bernie Sanders

Modern Medicine Needs Pot In A Pill

It's a perfect storm of opportunity.<br>With the opioid addiction crisis spiralling out of control, the medical community is desperate to find a new way …

Life Sciences

Thank a Pharmacist

Today is National Pharmacist Day. This post is a shout out to all the pharmacists across the country for being available (in many pharmacies) 24 …

Health

Science 37 reveals the potential for social media to be a hero for pharma

Health 2.0’s WinterTech conference offered some great examples of how far some companies have progressed regarding the role health IT entrepreneurs …

Health Care

Mylan’s branded EpiPen dropped from Cigna coverage list

Mylan is taking another hit tied to its EpiPen pricing controversy with Cigna now pushing patients toward the company’s new half-priced generic …

Health

RXi Pharma up 25%; OPKO takes 5% stake

In a 13G filed after the close yesterday, RXi Pharmaceuticals (RXII +24.6%) discloses a 446,360-share (5.1%) stake by OPKO Health (OPK +0.5%).<p>RXi …

Business

Allergan CEO: 2017 should be Kybella's breakout year

SAN FRANCISCO—Allergan CEO Brent Saunders is tired of hearing from investors that chin-fat buster Kybella’s launch isn’t going as well as, say, that …

Markets

Eli Lilly's Alimta escapes early generics—and a sales hit—with patent win over Teva

Chalk up a win for Eli Lilly in a much-watched patent tussle over the blockbuster cancer med Alimta. A federal appeals court said generic versions …

Patents

Kitov Pharma takes majority stake in TyrNovo in $3.8M cash-and-stock deal; shares up 5%

Thinly traded nano cap Kitov Pharmaceuticals (KTOV +5.1%) perks up on more than triple normal volume, albeit on turnover of only 243K shares, in …

Business

No new antidepressants likely in next decade, say scientists

Reluctance of healthcare providers such as NHS to pay for expensive drugs is behind lack of research, says Oxford professor<p>No new drugs for depression are likely in the next decade, even though those such as Prozac work for little more than half of those treated and there have been concerns over …

Life Sciences

Egypt raises prices on some medicines after currency plunge

CAIRO (Reuters) - Egypt will raise prices for a number of medicines after months of negotiations with pharmaceutical companies hurt by dollar shortages and a weakening currency, Health Minister Ahmed Rady said on Thursday.<p>The rises apply to 15 percent of domestically manufactured medicines and 20 …

Middle East